The publication of the NHS 10-Year Plan marks a pivotal moment for primary care, and a welcome validation of a principle we have championed for years. For too long, the full clinical potential of pharmacists and pharmacy technicians has been underutilised across the NHS.
In previous articles, we’ve made the case that, for primary care to realise the full return on their ARRS investment, the role of the pharmacist had to evolve. Now, with the 10-Year Plan’s focus on prevention, is it finally time for Pharmacists to shine?
Behind the change: Why the pharmacist role is changing
The demographic reality of an ageing population with increasingly complex co-morbidities can no longer be ignored. The recent Value in Health report from Carnall Farrar lays the problem bare, revealing that for common conditions like asthma and diabetes, up to 50% of patients are not receiving care that meets recommended clinical guidelines.
This creates significant “unmet care gaps” in treatment as people are not receiving the interventions that could prevent disease progression. This leads to poorer health outcomes and places an unsustainable burden on the health service.
The traditional primary care model, often focused on acute, single-issue appointments, struggles to provide the proactive, continuous, and specialist oversight that effective chronic disease management requires.
What does the 10-Year Plan say about pharmacists?
The 10-Year Plan establishes Neighbourhood Health Centres as hubs for integrated, multi-disciplinary teams (MDTs), with pharmacists as key “medicines experts.” The pharmacist becomes the go-to professional for GPs, nurses, social prescribers, and other allied health professionals for all medicine-related activities.
The plan also expands the pharmacist’s clinical role, emphasising their leadership in medicines optimisation and long-term condition management. By increasing the number of IP Pharmacists, pharmacy teams can operate with greater clinical autonomy, diagnosing, treating, and managing conditions from start to finish.
Meanwhile, advanced Pharmacy Technicians manage the vital operational workflow, such as conducting medicines reconciliation after hospital discharge, freeing IP Pharmacists to focus on clinical care.
How will the pharmacist’s role evolve?
For those of us who have long advocated for the transformation of the pharmacist’s role, this vision is not new. It’s the reality we have been building at Medacy for years.
Our founding ethos is that the true value of a pharmacist is only realised when they are empowered to lead clinically. It’s why all our pharmacists are Independent Prescribers, equipped to deliver the high-level care the 10-Year Plan calls for.
This evolution is happening on two key fronts:
1. Leading on Complex Care in the Neighbourhood
In the new model, pharmacists are empowered to take the lead on managing the most complex patients within a neighbourhood. This goes far beyond simple medication queries. It involves conducting in-depth Structured Medication Reviews, managing polypharmacy in frail or elderly patients, and running specialist clinics for long-term conditions like diabetes, asthma, or hypertension.
This pharmacist-led model underpins our Neighbourhood Health Service. The impact is transformative, reducing the clinical burden on GPs, preventing adverse drug events, and improving patient outcomes.
2. Driving System-Wide Strategy and Population Health
The pharmacist’s role is also expanding beyond the individual patient to a strategic, system-level function. With their unique expertise in medicines and data, pharmacists can analyse population health trends, design and implement effective prescribing strategies across an entire Integrated Care Board (ICB), and lead on initiatives to tackle health inequalities.
This strategic function is precisely what we deliver through our Integrated Care Boards (ICB) Service, proving that pharmacist leadership is essential for success, not just at the practice level, but across the entire system.
A Practical Example of Pharmacist-Led Care
To understand the impact, consider a patient like John…
John is 78, lives alone, and is managing Type 2 diabetes, COPD, and early-stage kidney disease. Under the current model, he might see his GP for a routine check, a nurse for his diabetes, and a different clinician for his COPD, with his repeat prescriptions managed reactively.
In the new model, an IP Pharmacist takes the lead on his care. During a comprehensive Structured Medication Review, the pharmacist notices a potential drug interaction between one of his medications and his declining kidney function. They de-prescribe the medication, switch him to a safer alternative, and create a simplified dosing schedule to improve his adherence.
The pharmacist also provides education on inhaler technique and liaises directly with his GP to update his care plan. This single, proactive intervention improves John’s quality of life and almost certainly prevents a future hospital admission.
At a strategic level, data from hundreds of ‘Johns’ can be analysed by pharmacists in our Integrated Care Boards (ICB) Service to drive system-wide improvements, proving that pharmacist leadership is essential at every level.
How to make the 10-Year Plan’s Vision a Reality?
The 10-Year Plan presents a significant culture change, and moving away from a traditional hierarchy to a truly collaborative MDT will be a challenge. It requires robust clinical governance and supervision to ensure patient safety and quality. It demands IT systems that are genuinely interoperable, allowing seamless sharing of patient records.
Most importantly, it requires true collaboration between people. From patient-facing front-line staff, through to the management of various NHS bodies, a culture of collaboration will need to be established.
There’s also a significant risk of under-utilisation. Hiring a highly-skilled IP Pharmacist and then limiting them to basic administrative tasks or pumping out SMRs is a waste of talent and resources.
Managed service, like Medacy, can be invaluable, providing the necessary training, clinical supervision, and operational framework to overcome these hurdles and ensure that PCNs and ICBs realise the full potential of their pharmacy teams.
The Future is Pharmacist-Led and Collaborative
The NHS 10-Year Plan provides the blueprint, but it is the action on the ground that will deliver change. The future of primary care, as the plan now formally acknowledges, depends on the clinical leadership of pharmacists. Moving them from a supporting role to a central one is the key to unlocking efficiency, improving patient outcomes, and creating a sustainable NHS.
This has been our firm belief for years, and we have built our services to prove it. The shift to Neighbourhood Health is here. We are ready to help you lead it.
To discuss how to embed this advanced pharmacist-led model in your organisation, contact our team today.
